Healthcare and Life Science
Raspberry PI corporate retreat at Barrington Hall
For the fifth consecutive year, Cambridge Dining Co. had the pleasure of delivering a seamless two-day corporate retreat for our valued client, Raspberry PI, hosted at our partner venue, Barrington Hall.Set against the autumnal grounds, the luxury marquee and historic Manor House provid...
Beyond the assay: why diagnostic device development needs three separate specifications
Beyond the Assay: Why Diagnostic Device Development Needs Three Separate SpecificationsWritten by Paul Edmondson - Director - eg technology ...
Eppendorf and BioLabs expand collaboration to support biotech innovation in Munich
• The collaboration will provide laboratory equipment, technical support and engagement opportunities for BioLabs resident companies • Builds on existing partnerships at BioLabs sites across the US, Germany and France ...
Takara Bio USA partners with SPT Labtech to deliver automation-ready NGS library preparation technologies
Trusted NGS chemistries from Takara Bio now optimized for firefly® automated workflows ...
ScionxBio announces collaboration to develop long-acting xRNA Therapeutics
Cambridge, UK, 20 October 2026: ScionxBio (the “company”, operating as a brand identity of Eleven Therapeutics Ltd. following a horizontal split) a privately held, preclinical-stage biotechnology company pioneering next-generation mRNA therapeutics, distinguished by their extended ...
Fashion fundraiser for Addenbrooke’s Charity spotlights secondary breast cancer
Bag a bargain. Inject some joy into your wardrobe. Support a great cause. Do all three at this weekend's Trash Chic charity sale. Taking place in the main mall of Cambridge’s Grand Arcade on Saturday, October 24, the event is being held in aid of Addenbrooke's Charity to support cancer ...
Qureight appointed imaging CRO for Phase 3 SURPASS-IPF trial as partnership with Celea Therapeutics expands
Celea has now contracted Qureight as the end-to-end imaging CRO for the phase 3 SURPASS-IPF trial, including Fibr8™ and four additional AI imaging models Joint poster at CHEST 2026 presents analysis completed as part of Qureight’s work on Celea’s phase 2b ELEVATE-IPF trial, compari...
Addenbrooke’s Charitable Trust wins Charity of the Year – and takes home four more awards – at the 2026 National Charity Today Awards
Addenbrooke’s Charitable Trust (ACT) has been crowned Charity of the Year at the 2026 National Charity Today Awards – widely recognised as the ‘Oscars’ of the charitable sector. ACT also topped the Fundraiser of the Year and public-voted People’s Choice Award categories, as well as bein...
What a UK Healthcare Degree Represents
By Lily Lin, CEO, Excellence First Enterprise Consultancy (EFEC)
Expanded international IP protection for concentrated ultra-rapid acting insulins enabling next generation of Automated Insulin Delivery (AID) systems
Arecor Therapeutics plc, a clinical stage biotech company developing superior therapeutics to reduce treatment burden and improve outcomes for people living with diabetes, obesity and other cardiometabolic diseases, has strengthened its patent protection for the company’s proprietary AT...